Announcement under Regulation 30 (LODR)-Updates on Acquisition 15 Sep - Completed first tranche investment of ₹5.999 crore in Black Tiger Distilleries; 12.5% stake acquired.
Source: Bse
FMCG stocks · Micro cap · NSE
Tilaknagar Industries Limited (TI) is an Indian alcoholic beverage company. It is India's largest brandy player with Mansion House Brandy surpassing 10 million cases in FY26. Post-Imperial Blue acquisition, TI is transitioning to a pan-India, pan-category player with a focus on premiumization and luxury segments.
MACD − · sector -5.7pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +155.8% · PAT -64.0% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
PAT -64% YoY · margin compression · Rev +156% YoY · +10% QoQ
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹1,046 Cr | +155.8% | +10.2% |
| EBITDA | ₹169 Cr | +79.8% | +9.0% |
| Operating margin | 16.0% | -700 bps | +0 bps |
| PAT | ₹32 Cr | -64.0% | NDF |
| PAT margin | 3.1% | -1870 bps | +464 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 21/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is weak — long-term uptrend intact. RSI 37.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 31 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
TI reports strong Q4 FY26 volume growth of 135% YoY to 8mn cases, driven by Imperial Blue acquisition. FY26 combined business volume grew 68% YoY to 20mn cases, with Mansion House Brandy reaching 10mn cases. EBITDA margin for Q4 and FY26 stood at 15.5%.
The acquisition of Imperial Blue has significantly boosted volumes and expanded TI's footprint. While integration costs and debt have increased, management has clear targets for margin expansion, debt reduction, and premium portfolio growth. The successful integration and realization of synergies are critical for the thesis.
Latest issuer-disclosed distribution across 2 reported categories.
Regain peak market share for Imperial Blue and expand its pan-India distribution.
Utilize IB's distribution strength to proliferate premium brands like Seven Islands Pure Malt Whisky and SSL portfolio in 10+ states.
Deliver growth in P&A brandy and continue as category leaders, ensuring brandy gets its 'Share of Voice'.
Planned expansion in manufacturing footprint to ensure supply-side safety and optimize overall footprint for operating leverage.
Government nod received for six-fold capacity expansion at Prag Distillery in Andhra Pradesh, from 6 lakh to 36 lakh cases per annum.
INR 59 crore capex investment for AP expansion is 100% completed, expected to cover ~50% of TI's AP requirements.
Successfully expanded TI’s manufacturing footprint across India in terms of units and bottling capacity, a mix of new units and brownfield expansion.
Acquisition of Imperial Blue provides pan-India distribution strength and significantly boosts combined business volumes.
Identified non-disruptive initiatives for packaging changes and new bottling arrangements to reduce costs, aiming for 250-400 bps margin expansion on acquired business.
Reduction in customs under India-UK FTA from 150% to 75% for scotch import.
AP is a 40 mn case IMFL market, growing at 15% p.a., where TI is the #1 P&A player.
Expect some pressure on input costs on account of current geo-political tensions, though hopeful impact will be short-lived.
Small business disruptions in the first couple of weeks of April 2026 due to TSMA exit, but bounced back in May.
Successful integration of Imperial Blue business, including manufacturing transition and cultural alignment, is ongoing.
Total Gross Debt increased to INR 2,295 crore in Mar-26 from INR 42 crore in Mar-25, with Net Debt at INR 1,911 crore.
Finance cost increased significantly to INR 69 crore in Q4 FY26 and INR 113 crore in FY26 due to acquisition-related borrowings.
Q4 FY26 includes INR 63 crores of exceptional items (TSMA/TSSA, transaction costs, labor code changes), impacting reported PAT.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is crucial for assessing the impact of the Imperial Blue acquisition on overall growth and profitability. QoQ comparison is important to monitor the sequential progress of Imperial Blue integration and manufacturing transition.
Q4 FY26 volumes grew 134.7% YoY to 8.0 mn cases. FY26 volumes grew 67.6% YoY to 20.0 mn cases.
Ex-IB business delivered 0.2% YoY volume growth in Q4 FY26 and 14.0% YoY growth in FY26.
Mansion House Brandy surpassed 10 million cases in sales in FY26, up from 8.7 million cases in FY25.
NSR for the combined business stands at INR 1,177/case in Q4 FY26, a 5.4% increase YoY.
Guidance for FY27 and next 3 years remains unchanged on both volume and margin fronts.
Target to achieve an EBITDA margin of 16-18% on combined business by FY29.
Reduce Net Debt / EBITDA below 1.0x.
Deliver a double-digit volume growth for existing brands including Imperial Blue; new launches will be additional.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Imperial Blue TSMA Exit | 3 states remain under TSMA. | Full exit from TSMA by Q4 FY27 and smooth transition of manufacturing operations. |
| EBITDA Margin | 15.5% (Q4 & FY26). | Progress towards 16-18% EBITDA margin target by FY29, indicating successful cost optimization and operating leverage. |
| Net Debt / EBITDA | 5.43x (INR 1,911 cr Net Debt / INR 352 cr FY26 EBITDA). | Reduction in Net Debt / EBITDA below 1.0x, indicating disciplined debt management and capital deployment. |
| Volume Growth (Ex-IB) | 14.0% YoY in FY26. | Sustained double-digit volume growth in the ex-IB business, alongside IB integration. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 20th percentile of the scored universe and 5th percentile within FMCG. Main check: results consistency is weak at 39/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · FMCG: 5th pctile, median 79 · Micro: 13th pctile, median 73
78 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse